author-photo

Angeliki Melidou

European Centre for Disease Prevention and Control

11

Papers

275

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

COVID-19 research priorities for non-pharmaceutical public health and social measures.

2021 Epidemiology and Infection
Show All
- Source
- Cite
- Save
Citations (4)
Spotlight influenza: The 2019/20 influenza season and the impact of COVID-19 on influenza surveillance in the WHO European Region.

2021 Eurosurveillance
Show All
- Source
- Cite
- Save
Citations (1)
Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021.

2021 Eurosurveillance
Show All
- Source
- Cite
- Save
Citations (25)
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

2021 Eurosurveillance
Show All
- Source
- Cite
- Save
Citations (90)
Testing indicators to monitor the COVID-19 pandemic.

2021 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.

2020 Vaccine
Show All
- Source
- Cite
- Save
Citations (2)
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

2020 Eurosurveillance
Show All
- Source
- Cite
- Save
Citations (126)
Alternating patterns of seasonal influenza activity in the WHO European Region following the 2009 pandemic, 2010‐2018

2020 Influenza and Other Respiratory Viruses
Show All
- Source
- Cite
- Save
Citations (4)
Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemic.

2020 Eurosurveillance
Show All
- Source
- Cite
- Save
Citations (7)
Variable sensitivity in molecular detection of SARS-CoV-2 in European Expert Laboratories: External Quality Assessment, June - July 2020.

2020 Journal of Clinical Microbiology
Show All
- Source
- Cite
- Save
Citations (7)